Claritev Corp

Claritev Corp, trading under the ticker CCXX, filed an 8-K current report with the Securities and Exchange Commission on May 1, 2025, accession number 0001793229-25-000084. Claritev Corp, the rebranded successor to MultiPlan Corporation, operates in the healthcare data analytics and cost management sector and reached the public markets through a SPAC merger with Churchill Capital Corp III, a blank-check company sponsored by M. Klein and Company, which completed its transaction in 2020. The 8-K represents a material event disclosure under standard SEC reporting requirements for publicly traded companies. Investors and analysts tracking post-merger SPAC operating companies in the healthcare technology space can access the full filing history, deal timeline, and structured data on Claritev Corp by signing up for a SpacDesk account at spacdesk.com.